Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency

Intern Med. 2023 Mar 15;62(6):871-875. doi: 10.2169/internalmedicine.0076-22. Epub 2022 Aug 10.

Abstract

Common variable immunodeficiency (CVID) causes granulomatous-lymphocytic interstitial lung disease (GLILD) and has a poor prognosis. We herein report a case of GLILD in a 49-year-old woman with CTLA-4 deficiency-associated CVID. The patient presented with dyspnea that had worsened over the past two years. A laboratory examination revealed hypoglobulinemia and pancytopenia. Chest computed tomography showed diffuse infiltrative and granular shadows in the bilateral interstitium. A flow cytometric analysis of blood cells and genetic testing confirmed CTLA-4 deficiency. We performed video-assisted thoracoscopic surgery for the pathological diagnosis of GLILD and to exclude infection and malignancy. Corticosteroid treatment successfully improved the condition of the patient.

Keywords: CTLA-4 deficiency; common variable immunodeficiency; corticosteroid; granulomatous-lymphocytic interstitial lung disease; video-assisted thoracoscopic surgery.

Publication types

  • Case Reports

MeSH terms

  • CTLA-4 Antigen
  • Common Variable Immunodeficiency* / complications
  • Common Variable Immunodeficiency* / diagnosis
  • Common Variable Immunodeficiency* / drug therapy
  • Female
  • Granuloma / diagnosis
  • Humans
  • Lung Diseases, Interstitial* / complications
  • Lung Diseases, Interstitial* / diagnostic imaging
  • Lung Diseases, Interstitial* / drug therapy
  • Middle Aged
  • Tomography, X-Ray Computed / adverse effects

Substances

  • CTLA-4 Antigen